Retrograde Chronic Total Occlusion Percutaneous Coronary Intervention via Saphenous Vein Graft
The aim of this study was to examine the use of saphenous vein grafts (SVGs) for retrograde crossing during chronic total occlusion (CTO) percutaneous coronary intervention (PCI). The use of SVGs for retrograde crossing during CTO PCI has received limited study. A total of 1,615 retrograde CTO PCIs...
Gespeichert in:
| Veröffentlicht in: | JACC. Cardiovascular interventions 2020-02, Vol.13 (4), p.517-526 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 526 |
|---|---|
| container_issue | 4 |
| container_start_page | 517 |
| container_title | JACC. Cardiovascular interventions |
| container_volume | 13 |
| creator | Xenogiannis, Iosif Gkargkoulas, Fotis Karmpaliotis, Dimitri Krestyaninov, Oleg Khelimskii, Dmitrii Jaffer, Farouc A. Khatri, Jaikirshan J. Kandzari, David E. Wyman, R. Michael Doing, Anthony H. Dattilo, Phil Toma, Catalin Yeh, Robert W. Tamez, Hector Choi, James W. Jaber, Wissam Samady, Habib Sheikh, Abdul M. Potluri, Srinivasa Patel, Mitul Mahmud, Ehtisham Elbaruni, Basem Love, Michael P. Koutouzis, Michalis Tsiafoutis, Ioannis Jefferson, Brian K. Patel, Taral Uretsky, Barry Moses, Jeffrey W. Lembo, Nicholas J. Parikh, Manish Kirtane, Ajay J. Ali, Ziad A. Hall, Allison B. Megaly, Michael S. Vemmou, Evangelia Nikolakopoulos, Ilias Rangan, Bavana V. Morley, Pamela W. Bou Dargham, Bassel Abdullah, Shuaib Garcia, Santiago Banerjee, Subhash Burke, M. Nicholas Brilakis, Emmanouil S. Alaswad, Khaldoon |
| description | The aim of this study was to examine the use of saphenous vein grafts (SVGs) for retrograde crossing during chronic total occlusion (CTO) percutaneous coronary intervention (PCI).
The use of SVGs for retrograde crossing during CTO PCI has received limited study.
A total of 1,615 retrograde CTO PCIs performed between 2012 and 2019 at 25 centers were examined. Clinical, angiographic, and technical characteristics and procedural outcomes were compared among retrograde cases via SVGs (SVG group) versus other collateral vessels (non-SVG group).
Retrograde CTO PCI via SVGs was performed in 189 cases (12%). Patients in the SVG group were older (mean age 70 ± 9 years vs. 64 ± 10 years; p |
| doi_str_mv | 10.1016/j.jcin.2019.10.028 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2428067122</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1936879819322186</els_id><sourcerecordid>2428067122</sourcerecordid><originalsourceid>FETCH-LOGICAL-c400t-a999272b7c5b181526ec8a4488c75a6f999647e9a1cd14f86bffe47ab3b6f1613</originalsourceid><addsrcrecordid>eNp9kEtOwzAQhi0EolC4AAuUJZsU20ltR2KDKl4SEojX1nKcCXWV2sV2KnEbzsLJcNTCktWMxt_88nwInRA8IZiw88VkoY2dUEyqNJhgKnbQARGc5Zzh6W7qq4LlgldihA5DWGDMcMXpPhoVFAtCy-IAySeI3r171UA2m3tnjc5eXFRd9qB11wfjbPYIXvdRWXB9yGYuQcp_Znc2gl-DjQOyNur761mt5mAH6A2MzW68auMR2mtVF-B4W8fo9frqZXab3z_c3M0u73NdYhxzVVUV5bTmeloTQaaUgRaqLIXQfKpYm55ZyaFSRDekbAWr2xZKruqiZi1hpBijs03uyruPHkKUSxM0dN3m25KWVGDGCaUJpRtUexeCh1auvFmmkyTBchArF3IQKwexwyyJTUun2_y-XkLzt_JrMgEXGwDSlWsDXgZtwGpojAcdZePMf_k_esOLgw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2428067122</pqid></control><display><type>article</type><title>Retrograde Chronic Total Occlusion Percutaneous Coronary Intervention via Saphenous Vein Graft</title><source>Elsevier ScienceDirect Journals Complete</source><source>EZB-FREE-00999 freely available EZB journals</source><creator>Xenogiannis, Iosif ; Gkargkoulas, Fotis ; Karmpaliotis, Dimitri ; Krestyaninov, Oleg ; Khelimskii, Dmitrii ; Jaffer, Farouc A. ; Khatri, Jaikirshan J. ; Kandzari, David E. ; Wyman, R. Michael ; Doing, Anthony H. ; Dattilo, Phil ; Toma, Catalin ; Yeh, Robert W. ; Tamez, Hector ; Choi, James W. ; Jaber, Wissam ; Samady, Habib ; Sheikh, Abdul M. ; Potluri, Srinivasa ; Patel, Mitul ; Mahmud, Ehtisham ; Elbaruni, Basem ; Love, Michael P. ; Koutouzis, Michalis ; Tsiafoutis, Ioannis ; Jefferson, Brian K. ; Patel, Taral ; Uretsky, Barry ; Moses, Jeffrey W. ; Lembo, Nicholas J. ; Parikh, Manish ; Kirtane, Ajay J. ; Ali, Ziad A. ; Hall, Allison B. ; Megaly, Michael S. ; Vemmou, Evangelia ; Nikolakopoulos, Ilias ; Rangan, Bavana V. ; Morley, Pamela W. ; Bou Dargham, Bassel ; Abdullah, Shuaib ; Garcia, Santiago ; Banerjee, Subhash ; Burke, M. Nicholas ; Brilakis, Emmanouil S. ; Alaswad, Khaldoon</creator><creatorcontrib>Xenogiannis, Iosif ; Gkargkoulas, Fotis ; Karmpaliotis, Dimitri ; Krestyaninov, Oleg ; Khelimskii, Dmitrii ; Jaffer, Farouc A. ; Khatri, Jaikirshan J. ; Kandzari, David E. ; Wyman, R. Michael ; Doing, Anthony H. ; Dattilo, Phil ; Toma, Catalin ; Yeh, Robert W. ; Tamez, Hector ; Choi, James W. ; Jaber, Wissam ; Samady, Habib ; Sheikh, Abdul M. ; Potluri, Srinivasa ; Patel, Mitul ; Mahmud, Ehtisham ; Elbaruni, Basem ; Love, Michael P. ; Koutouzis, Michalis ; Tsiafoutis, Ioannis ; Jefferson, Brian K. ; Patel, Taral ; Uretsky, Barry ; Moses, Jeffrey W. ; Lembo, Nicholas J. ; Parikh, Manish ; Kirtane, Ajay J. ; Ali, Ziad A. ; Hall, Allison B. ; Megaly, Michael S. ; Vemmou, Evangelia ; Nikolakopoulos, Ilias ; Rangan, Bavana V. ; Morley, Pamela W. ; Bou Dargham, Bassel ; Abdullah, Shuaib ; Garcia, Santiago ; Banerjee, Subhash ; Burke, M. Nicholas ; Brilakis, Emmanouil S. ; Alaswad, Khaldoon</creatorcontrib><description><![CDATA[The aim of this study was to examine the use of saphenous vein grafts (SVGs) for retrograde crossing during chronic total occlusion (CTO) percutaneous coronary intervention (PCI).
The use of SVGs for retrograde crossing during CTO PCI has received limited study.
A total of 1,615 retrograde CTO PCIs performed between 2012 and 2019 at 25 centers were examined. Clinical, angiographic, and technical characteristics and procedural outcomes were compared among retrograde cases via SVGs (SVG group) versus other collateral vessels (non-SVG group).
Retrograde CTO PCI via SVGs was performed in 189 cases (12%). Patients in the SVG group were older (mean age 70 ± 9 years vs. 64 ± 10 years; p < 0.01) and had higher rates of prior myocardial infarction (62% vs. 51%; p < 0.01) and prior PCI (81% vs. 70%; p < 0.01). They were more likely to have moderate or severe calcification (81% vs. 65%; p < 0.01) and moderate or severe tortuosity (53% vs. 44%; p = 0.02) and had similar J-CTO (Multicenter CTO Registry in Japan) scores (3.2 ± 1.0 vs. 3.1 ± 1.1; p = 0.13) but higher PROGRESS-CTO (Prospective Global Registry for the Study of Chronic Total Occlusion Intervention) scores (4.7 ± 1.7 vs. 3.1 ± 1.1; p < 0.01). Technical (85% vs. 78%; p = 0.04) and procedural (81% vs. 74%; p = 0.04) success rates were higher in the SVG group, with no difference in in-hospital major adverse events (6.4% vs. 4.4%; p = 0.22). Contrast volume was lower in the SVG group (225 ml [173 to 325 ml] vs. 292 ml [202 to 400 ml]; p < 0.01).
Use of SVGs for retrograde crossing is associated with higher rates of technical and procedural success and similar rates of in-hospital major adverse cardiac events compared with retrograde CTO PCI via other collateral vessels.
[Display omitted]]]></description><identifier>ISSN: 1936-8798</identifier><identifier>EISSN: 1876-7605</identifier><identifier>DOI: 10.1016/j.jcin.2019.10.028</identifier><identifier>PMID: 32081243</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>chronic total occlusion ; collateral ; percutaneous coronary interventions ; retrograde approach ; saphenous vein grafts</subject><ispartof>JACC. Cardiovascular interventions, 2020-02, Vol.13 (4), p.517-526</ispartof><rights>2020 American College of Cardiology Foundation</rights><rights>Copyright © 2020 American College of Cardiology Foundation. All rights reserved.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c400t-a999272b7c5b181526ec8a4488c75a6f999647e9a1cd14f86bffe47ab3b6f1613</citedby><cites>FETCH-LOGICAL-c400t-a999272b7c5b181526ec8a4488c75a6f999647e9a1cd14f86bffe47ab3b6f1613</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.jcin.2019.10.028$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32081243$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Xenogiannis, Iosif</creatorcontrib><creatorcontrib>Gkargkoulas, Fotis</creatorcontrib><creatorcontrib>Karmpaliotis, Dimitri</creatorcontrib><creatorcontrib>Krestyaninov, Oleg</creatorcontrib><creatorcontrib>Khelimskii, Dmitrii</creatorcontrib><creatorcontrib>Jaffer, Farouc A.</creatorcontrib><creatorcontrib>Khatri, Jaikirshan J.</creatorcontrib><creatorcontrib>Kandzari, David E.</creatorcontrib><creatorcontrib>Wyman, R. Michael</creatorcontrib><creatorcontrib>Doing, Anthony H.</creatorcontrib><creatorcontrib>Dattilo, Phil</creatorcontrib><creatorcontrib>Toma, Catalin</creatorcontrib><creatorcontrib>Yeh, Robert W.</creatorcontrib><creatorcontrib>Tamez, Hector</creatorcontrib><creatorcontrib>Choi, James W.</creatorcontrib><creatorcontrib>Jaber, Wissam</creatorcontrib><creatorcontrib>Samady, Habib</creatorcontrib><creatorcontrib>Sheikh, Abdul M.</creatorcontrib><creatorcontrib>Potluri, Srinivasa</creatorcontrib><creatorcontrib>Patel, Mitul</creatorcontrib><creatorcontrib>Mahmud, Ehtisham</creatorcontrib><creatorcontrib>Elbaruni, Basem</creatorcontrib><creatorcontrib>Love, Michael P.</creatorcontrib><creatorcontrib>Koutouzis, Michalis</creatorcontrib><creatorcontrib>Tsiafoutis, Ioannis</creatorcontrib><creatorcontrib>Jefferson, Brian K.</creatorcontrib><creatorcontrib>Patel, Taral</creatorcontrib><creatorcontrib>Uretsky, Barry</creatorcontrib><creatorcontrib>Moses, Jeffrey W.</creatorcontrib><creatorcontrib>Lembo, Nicholas J.</creatorcontrib><creatorcontrib>Parikh, Manish</creatorcontrib><creatorcontrib>Kirtane, Ajay J.</creatorcontrib><creatorcontrib>Ali, Ziad A.</creatorcontrib><creatorcontrib>Hall, Allison B.</creatorcontrib><creatorcontrib>Megaly, Michael S.</creatorcontrib><creatorcontrib>Vemmou, Evangelia</creatorcontrib><creatorcontrib>Nikolakopoulos, Ilias</creatorcontrib><creatorcontrib>Rangan, Bavana V.</creatorcontrib><creatorcontrib>Morley, Pamela W.</creatorcontrib><creatorcontrib>Bou Dargham, Bassel</creatorcontrib><creatorcontrib>Abdullah, Shuaib</creatorcontrib><creatorcontrib>Garcia, Santiago</creatorcontrib><creatorcontrib>Banerjee, Subhash</creatorcontrib><creatorcontrib>Burke, M. Nicholas</creatorcontrib><creatorcontrib>Brilakis, Emmanouil S.</creatorcontrib><creatorcontrib>Alaswad, Khaldoon</creatorcontrib><title>Retrograde Chronic Total Occlusion Percutaneous Coronary Intervention via Saphenous Vein Graft</title><title>JACC. Cardiovascular interventions</title><addtitle>JACC Cardiovasc Interv</addtitle><description><![CDATA[The aim of this study was to examine the use of saphenous vein grafts (SVGs) for retrograde crossing during chronic total occlusion (CTO) percutaneous coronary intervention (PCI).
The use of SVGs for retrograde crossing during CTO PCI has received limited study.
A total of 1,615 retrograde CTO PCIs performed between 2012 and 2019 at 25 centers were examined. Clinical, angiographic, and technical characteristics and procedural outcomes were compared among retrograde cases via SVGs (SVG group) versus other collateral vessels (non-SVG group).
Retrograde CTO PCI via SVGs was performed in 189 cases (12%). Patients in the SVG group were older (mean age 70 ± 9 years vs. 64 ± 10 years; p < 0.01) and had higher rates of prior myocardial infarction (62% vs. 51%; p < 0.01) and prior PCI (81% vs. 70%; p < 0.01). They were more likely to have moderate or severe calcification (81% vs. 65%; p < 0.01) and moderate or severe tortuosity (53% vs. 44%; p = 0.02) and had similar J-CTO (Multicenter CTO Registry in Japan) scores (3.2 ± 1.0 vs. 3.1 ± 1.1; p = 0.13) but higher PROGRESS-CTO (Prospective Global Registry for the Study of Chronic Total Occlusion Intervention) scores (4.7 ± 1.7 vs. 3.1 ± 1.1; p < 0.01). Technical (85% vs. 78%; p = 0.04) and procedural (81% vs. 74%; p = 0.04) success rates were higher in the SVG group, with no difference in in-hospital major adverse events (6.4% vs. 4.4%; p = 0.22). Contrast volume was lower in the SVG group (225 ml [173 to 325 ml] vs. 292 ml [202 to 400 ml]; p < 0.01).
Use of SVGs for retrograde crossing is associated with higher rates of technical and procedural success and similar rates of in-hospital major adverse cardiac events compared with retrograde CTO PCI via other collateral vessels.
[Display omitted]]]></description><subject>chronic total occlusion</subject><subject>collateral</subject><subject>percutaneous coronary interventions</subject><subject>retrograde approach</subject><subject>saphenous vein grafts</subject><issn>1936-8798</issn><issn>1876-7605</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><recordid>eNp9kEtOwzAQhi0EolC4AAuUJZsU20ltR2KDKl4SEojX1nKcCXWV2sV2KnEbzsLJcNTCktWMxt_88nwInRA8IZiw88VkoY2dUEyqNJhgKnbQARGc5Zzh6W7qq4LlgldihA5DWGDMcMXpPhoVFAtCy-IAySeI3r171UA2m3tnjc5eXFRd9qB11wfjbPYIXvdRWXB9yGYuQcp_Znc2gl-DjQOyNur761mt5mAH6A2MzW68auMR2mtVF-B4W8fo9frqZXab3z_c3M0u73NdYhxzVVUV5bTmeloTQaaUgRaqLIXQfKpYm55ZyaFSRDekbAWr2xZKruqiZi1hpBijs03uyruPHkKUSxM0dN3m25KWVGDGCaUJpRtUexeCh1auvFmmkyTBchArF3IQKwexwyyJTUun2_y-XkLzt_JrMgEXGwDSlWsDXgZtwGpojAcdZePMf_k_esOLgw</recordid><startdate>20200224</startdate><enddate>20200224</enddate><creator>Xenogiannis, Iosif</creator><creator>Gkargkoulas, Fotis</creator><creator>Karmpaliotis, Dimitri</creator><creator>Krestyaninov, Oleg</creator><creator>Khelimskii, Dmitrii</creator><creator>Jaffer, Farouc A.</creator><creator>Khatri, Jaikirshan J.</creator><creator>Kandzari, David E.</creator><creator>Wyman, R. Michael</creator><creator>Doing, Anthony H.</creator><creator>Dattilo, Phil</creator><creator>Toma, Catalin</creator><creator>Yeh, Robert W.</creator><creator>Tamez, Hector</creator><creator>Choi, James W.</creator><creator>Jaber, Wissam</creator><creator>Samady, Habib</creator><creator>Sheikh, Abdul M.</creator><creator>Potluri, Srinivasa</creator><creator>Patel, Mitul</creator><creator>Mahmud, Ehtisham</creator><creator>Elbaruni, Basem</creator><creator>Love, Michael P.</creator><creator>Koutouzis, Michalis</creator><creator>Tsiafoutis, Ioannis</creator><creator>Jefferson, Brian K.</creator><creator>Patel, Taral</creator><creator>Uretsky, Barry</creator><creator>Moses, Jeffrey W.</creator><creator>Lembo, Nicholas J.</creator><creator>Parikh, Manish</creator><creator>Kirtane, Ajay J.</creator><creator>Ali, Ziad A.</creator><creator>Hall, Allison B.</creator><creator>Megaly, Michael S.</creator><creator>Vemmou, Evangelia</creator><creator>Nikolakopoulos, Ilias</creator><creator>Rangan, Bavana V.</creator><creator>Morley, Pamela W.</creator><creator>Bou Dargham, Bassel</creator><creator>Abdullah, Shuaib</creator><creator>Garcia, Santiago</creator><creator>Banerjee, Subhash</creator><creator>Burke, M. Nicholas</creator><creator>Brilakis, Emmanouil S.</creator><creator>Alaswad, Khaldoon</creator><general>Elsevier Inc</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20200224</creationdate><title>Retrograde Chronic Total Occlusion Percutaneous Coronary Intervention via Saphenous Vein Graft</title><author>Xenogiannis, Iosif ; Gkargkoulas, Fotis ; Karmpaliotis, Dimitri ; Krestyaninov, Oleg ; Khelimskii, Dmitrii ; Jaffer, Farouc A. ; Khatri, Jaikirshan J. ; Kandzari, David E. ; Wyman, R. Michael ; Doing, Anthony H. ; Dattilo, Phil ; Toma, Catalin ; Yeh, Robert W. ; Tamez, Hector ; Choi, James W. ; Jaber, Wissam ; Samady, Habib ; Sheikh, Abdul M. ; Potluri, Srinivasa ; Patel, Mitul ; Mahmud, Ehtisham ; Elbaruni, Basem ; Love, Michael P. ; Koutouzis, Michalis ; Tsiafoutis, Ioannis ; Jefferson, Brian K. ; Patel, Taral ; Uretsky, Barry ; Moses, Jeffrey W. ; Lembo, Nicholas J. ; Parikh, Manish ; Kirtane, Ajay J. ; Ali, Ziad A. ; Hall, Allison B. ; Megaly, Michael S. ; Vemmou, Evangelia ; Nikolakopoulos, Ilias ; Rangan, Bavana V. ; Morley, Pamela W. ; Bou Dargham, Bassel ; Abdullah, Shuaib ; Garcia, Santiago ; Banerjee, Subhash ; Burke, M. Nicholas ; Brilakis, Emmanouil S. ; Alaswad, Khaldoon</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c400t-a999272b7c5b181526ec8a4488c75a6f999647e9a1cd14f86bffe47ab3b6f1613</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>chronic total occlusion</topic><topic>collateral</topic><topic>percutaneous coronary interventions</topic><topic>retrograde approach</topic><topic>saphenous vein grafts</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Xenogiannis, Iosif</creatorcontrib><creatorcontrib>Gkargkoulas, Fotis</creatorcontrib><creatorcontrib>Karmpaliotis, Dimitri</creatorcontrib><creatorcontrib>Krestyaninov, Oleg</creatorcontrib><creatorcontrib>Khelimskii, Dmitrii</creatorcontrib><creatorcontrib>Jaffer, Farouc A.</creatorcontrib><creatorcontrib>Khatri, Jaikirshan J.</creatorcontrib><creatorcontrib>Kandzari, David E.</creatorcontrib><creatorcontrib>Wyman, R. Michael</creatorcontrib><creatorcontrib>Doing, Anthony H.</creatorcontrib><creatorcontrib>Dattilo, Phil</creatorcontrib><creatorcontrib>Toma, Catalin</creatorcontrib><creatorcontrib>Yeh, Robert W.</creatorcontrib><creatorcontrib>Tamez, Hector</creatorcontrib><creatorcontrib>Choi, James W.</creatorcontrib><creatorcontrib>Jaber, Wissam</creatorcontrib><creatorcontrib>Samady, Habib</creatorcontrib><creatorcontrib>Sheikh, Abdul M.</creatorcontrib><creatorcontrib>Potluri, Srinivasa</creatorcontrib><creatorcontrib>Patel, Mitul</creatorcontrib><creatorcontrib>Mahmud, Ehtisham</creatorcontrib><creatorcontrib>Elbaruni, Basem</creatorcontrib><creatorcontrib>Love, Michael P.</creatorcontrib><creatorcontrib>Koutouzis, Michalis</creatorcontrib><creatorcontrib>Tsiafoutis, Ioannis</creatorcontrib><creatorcontrib>Jefferson, Brian K.</creatorcontrib><creatorcontrib>Patel, Taral</creatorcontrib><creatorcontrib>Uretsky, Barry</creatorcontrib><creatorcontrib>Moses, Jeffrey W.</creatorcontrib><creatorcontrib>Lembo, Nicholas J.</creatorcontrib><creatorcontrib>Parikh, Manish</creatorcontrib><creatorcontrib>Kirtane, Ajay J.</creatorcontrib><creatorcontrib>Ali, Ziad A.</creatorcontrib><creatorcontrib>Hall, Allison B.</creatorcontrib><creatorcontrib>Megaly, Michael S.</creatorcontrib><creatorcontrib>Vemmou, Evangelia</creatorcontrib><creatorcontrib>Nikolakopoulos, Ilias</creatorcontrib><creatorcontrib>Rangan, Bavana V.</creatorcontrib><creatorcontrib>Morley, Pamela W.</creatorcontrib><creatorcontrib>Bou Dargham, Bassel</creatorcontrib><creatorcontrib>Abdullah, Shuaib</creatorcontrib><creatorcontrib>Garcia, Santiago</creatorcontrib><creatorcontrib>Banerjee, Subhash</creatorcontrib><creatorcontrib>Burke, M. Nicholas</creatorcontrib><creatorcontrib>Brilakis, Emmanouil S.</creatorcontrib><creatorcontrib>Alaswad, Khaldoon</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>JACC. Cardiovascular interventions</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Xenogiannis, Iosif</au><au>Gkargkoulas, Fotis</au><au>Karmpaliotis, Dimitri</au><au>Krestyaninov, Oleg</au><au>Khelimskii, Dmitrii</au><au>Jaffer, Farouc A.</au><au>Khatri, Jaikirshan J.</au><au>Kandzari, David E.</au><au>Wyman, R. Michael</au><au>Doing, Anthony H.</au><au>Dattilo, Phil</au><au>Toma, Catalin</au><au>Yeh, Robert W.</au><au>Tamez, Hector</au><au>Choi, James W.</au><au>Jaber, Wissam</au><au>Samady, Habib</au><au>Sheikh, Abdul M.</au><au>Potluri, Srinivasa</au><au>Patel, Mitul</au><au>Mahmud, Ehtisham</au><au>Elbaruni, Basem</au><au>Love, Michael P.</au><au>Koutouzis, Michalis</au><au>Tsiafoutis, Ioannis</au><au>Jefferson, Brian K.</au><au>Patel, Taral</au><au>Uretsky, Barry</au><au>Moses, Jeffrey W.</au><au>Lembo, Nicholas J.</au><au>Parikh, Manish</au><au>Kirtane, Ajay J.</au><au>Ali, Ziad A.</au><au>Hall, Allison B.</au><au>Megaly, Michael S.</au><au>Vemmou, Evangelia</au><au>Nikolakopoulos, Ilias</au><au>Rangan, Bavana V.</au><au>Morley, Pamela W.</au><au>Bou Dargham, Bassel</au><au>Abdullah, Shuaib</au><au>Garcia, Santiago</au><au>Banerjee, Subhash</au><au>Burke, M. Nicholas</au><au>Brilakis, Emmanouil S.</au><au>Alaswad, Khaldoon</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Retrograde Chronic Total Occlusion Percutaneous Coronary Intervention via Saphenous Vein Graft</atitle><jtitle>JACC. Cardiovascular interventions</jtitle><addtitle>JACC Cardiovasc Interv</addtitle><date>2020-02-24</date><risdate>2020</risdate><volume>13</volume><issue>4</issue><spage>517</spage><epage>526</epage><pages>517-526</pages><issn>1936-8798</issn><eissn>1876-7605</eissn><abstract><![CDATA[The aim of this study was to examine the use of saphenous vein grafts (SVGs) for retrograde crossing during chronic total occlusion (CTO) percutaneous coronary intervention (PCI).
The use of SVGs for retrograde crossing during CTO PCI has received limited study.
A total of 1,615 retrograde CTO PCIs performed between 2012 and 2019 at 25 centers were examined. Clinical, angiographic, and technical characteristics and procedural outcomes were compared among retrograde cases via SVGs (SVG group) versus other collateral vessels (non-SVG group).
Retrograde CTO PCI via SVGs was performed in 189 cases (12%). Patients in the SVG group were older (mean age 70 ± 9 years vs. 64 ± 10 years; p < 0.01) and had higher rates of prior myocardial infarction (62% vs. 51%; p < 0.01) and prior PCI (81% vs. 70%; p < 0.01). They were more likely to have moderate or severe calcification (81% vs. 65%; p < 0.01) and moderate or severe tortuosity (53% vs. 44%; p = 0.02) and had similar J-CTO (Multicenter CTO Registry in Japan) scores (3.2 ± 1.0 vs. 3.1 ± 1.1; p = 0.13) but higher PROGRESS-CTO (Prospective Global Registry for the Study of Chronic Total Occlusion Intervention) scores (4.7 ± 1.7 vs. 3.1 ± 1.1; p < 0.01). Technical (85% vs. 78%; p = 0.04) and procedural (81% vs. 74%; p = 0.04) success rates were higher in the SVG group, with no difference in in-hospital major adverse events (6.4% vs. 4.4%; p = 0.22). Contrast volume was lower in the SVG group (225 ml [173 to 325 ml] vs. 292 ml [202 to 400 ml]; p < 0.01).
Use of SVGs for retrograde crossing is associated with higher rates of technical and procedural success and similar rates of in-hospital major adverse cardiac events compared with retrograde CTO PCI via other collateral vessels.
[Display omitted]]]></abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>32081243</pmid><doi>10.1016/j.jcin.2019.10.028</doi><tpages>10</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1936-8798 |
| ispartof | JACC. Cardiovascular interventions, 2020-02, Vol.13 (4), p.517-526 |
| issn | 1936-8798 1876-7605 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_2428067122 |
| source | Elsevier ScienceDirect Journals Complete; EZB-FREE-00999 freely available EZB journals |
| subjects | chronic total occlusion collateral percutaneous coronary interventions retrograde approach saphenous vein grafts |
| title | Retrograde Chronic Total Occlusion Percutaneous Coronary Intervention via Saphenous Vein Graft |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-25T15%3A30%3A26IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Retrograde%20Chronic%20Total%20Occlusion%20Percutaneous%20Coronary%20Intervention%20via%C2%A0Saphenous%20Vein%20Graft&rft.jtitle=JACC.%20Cardiovascular%20interventions&rft.au=Xenogiannis,%20Iosif&rft.date=2020-02-24&rft.volume=13&rft.issue=4&rft.spage=517&rft.epage=526&rft.pages=517-526&rft.issn=1936-8798&rft.eissn=1876-7605&rft_id=info:doi/10.1016/j.jcin.2019.10.028&rft_dat=%3Cproquest_cross%3E2428067122%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2428067122&rft_id=info:pmid/32081243&rft_els_id=S1936879819322186&rfr_iscdi=true |